Company Name: Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The company is engaged in the development of treatments for rare diseases. The company’s therapeutic focus is on homozygous familial hypercholesterolemia (HoFH).
Ticker Symbol: AEGR (NASDAQ)
Company Website: www.aegerion.com
Social Media: Aegerion Pharmaceuticals LinkedIn
Headquarters: Cambridge, MA